← Leaderboards
Daniel Vincent Zurawski
University Of Colorado
$595,390
Attributed
$2,081,563
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $507.3K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,081,563 · 2
By mechanism
R01$1,781,568 · 1
R43$299,995 · 1
Top collaborators
- Dan L. Feldheim4 shared
- Ryan T Gill4 shared
- Christian C Melander4 shared
- Alex Sajovic Moreland1 shared
Most similar at University Of Colorado
Same institution · by research overlap
- Dan L. Feldheim$2,738,890
- Taeyoung Hwang$1,306,040
- Giulia Irene Maria Pasquesi$250,000
- Maciej Walczak$8,491,186
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsStructure-Activity RelationshipGrowthPathogenSmall MoleculeStructureEscherichia ColiGram-Negative BacteriaInfectionMulti-Drug ResistanceScaffoldDesignBacteriaAntibioticsChemistryBactericideCessation Of LifeFutureAntimicrobialCombatIn VivoLeadResistanceToxic Effect
Grant awards (5)
New Antimicrobials that Act Via Membrane Remodeling for Critical Gram-Negative Pathogens$299,995
R43 · FY2024 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$507,293
R01 · FY2017 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$436,530
R01 · FY2016 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$412,744
R01 · FY2015 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$425,001
R01 · FY2014 · AI